Clincosm LogoSign in Get a demo

nonalcoholic fatty liver

Showing 1 - 25 of 28
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Accurate Point of Care Liver Disease Diagnostics

Recruiting
  • NAFLD
  • Nonalcoholic Fatty Liver
  • Liverscope® exam
  • +5 more
  • La Jolla, California
    University of California San Diego
Aug 8, 2023

Overweight and Obese Children

Not yet recruiting
  • Pediatric Obesity
  • +5 more
  • History and Clinical evaluation
  • +4 more
  • Timişoara, Timiş, Romania
    Neoped - Centru de Pediatrie
Jun 14, 2023

Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis, Fatty Liver Trial in Boston (GE ultrasound system with increased

Not yet recruiting
  • Nonalcoholic Fatty Liver
  • +2 more
  • GE ultrasound system with increased acoustic output settings
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 19, 2023

Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis Trial in Germany, Spain, United States

Recruiting
  • Nonalcoholic Fatty Liver
  • Nonalcoholic Steatohepatitis
    • Phoenix, Arizona
    • +73 more
    Nov 3, 2022

    NAFLD, Nonalcoholic Fatty Liver, NASH - Nonalcoholic Steatohepatitis Trial (LUM-201)

    Recruiting
    • NAFLD
    • +2 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Sep 26, 2022

    Iron, Diabetes, Nonalcoholic Fatty Liver Trial in Chapel Hill, Winston-Salem (Blood Donation, Sham Blood Donation)

    Recruiting
    • Iron
    • +2 more
    • Blood Donation
    • Sham Blood Donation
    • Chapel Hill, North Carolina
    • +1 more
    Sep 26, 2022

    Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis Trial in Yokohama (Experimental: 4 mg/day of WY-8678 (guanabenz acetate),

    Active, not recruiting
    • Nonalcoholic Fatty Liver
    • Nonalcoholic Steatohepatitis
    • Experimental: 4 mg/day of WY-8678 (guanabenz acetate)
    • Experimental: 8 mg/day of WY-8678 (guanabenz acetate)
    • Yokohama, Kanagawa, Japan
      Yokohama City University
    Sep 25, 2022

    NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes

    Active, not recruiting
    • Nonalcoholic Fatty Liver
    • +4 more
    • Transient Elastography
    • Boston, Massachusetts
      Joslin Diabetes Center
    Sep 16, 2022

    Nonalcoholic Fatty Liver, Osteoporosis, Postmenopausal Trial (Denosumab, Alendronate Sodium)

    Not yet recruiting
    • Nonalcoholic Fatty Liver
    • Osteoporosis, Postmenopausal
    • (no location specified)
    Aug 6, 2022

    Metabolic Pathology of Pediatric NAFLD

    Recruiting
    • Nonalcoholic Fatty Liver
    • +2 more
    • Cardiometabolic testing
    • Oklahoma City, Oklahoma
      University of Oklahoma Health Sciences Center
    Jun 28, 2022

    Nonalcoholic Steatohepatitis, Nonalcoholic Fatty Liver Trial in San Diego, Boston (device, diagnostic test, other)

    Completed
    • Nonalcoholic Steatohepatitis
    • Nonalcoholic Fatty Liver
    • Ultrasound based shear wave speed and fat quantification methods
    • +3 more
    • San Diego, California
    • +1 more
    Apr 11, 2022

    Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis Trial in Seoul (Intermittent calorie restriction, Standard of care)

    Recruiting
    • Nonalcoholic Fatty Liver
    • Nonalcoholic Steatohepatitis
    • Intermittent calorie restriction
    • Standard of care
    • Seoul, Yangcheon-gu, Korea, Republic of
      Ewha Womans University College of Medicine
    Mar 24, 2022

    Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis Trial in Boston (Aspirin 81 mg, Placebo oral tablet)

    Recruiting
    • Nonalcoholic Fatty Liver
    • Nonalcoholic Steatohepatitis
    • Aspirin 81 mg
    • Placebo oral tablet
    • Boston, Massachusetts
      Massachusetts General Hospital
    Feb 23, 2022

    Nonalcoholic Fatty Liver, Weight Loss Trial (GS300, Placebo)

    Not yet recruiting
    • Nonalcoholic Fatty Liver
    • Weight Loss
    • GS300
    • Placebo
    • (no location specified)
    Jan 21, 2022

    Diabetes, Type 2, PreDiabetes, Insulin Resistance Trial in Stanford (Dietary Intervention)

    Recruiting
    • Diabetes Mellitus, Type 2
    • +6 more
    • Dietary Intervention
    • Stanford, California
      Stanford University
    Dec 7, 2021

    Metabolic Liver Disease (NIMBLE) Study 1.2

    Recruiting
    • Nonalcoholic Fatty Liver
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Nov 29, 2021

      Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis Trial in Yokohama (Elobixibat 10mg + cholestyramine powder 9g

      Completed
      • Nonalcoholic Fatty Liver
      • Nonalcoholic Steatohepatitis
      • Elobixibat 10mg + cholestyramine powder 9g (cholestyramine 4g)
      • +3 more
      • Yokohama, Kanagawa, Japan
        Yokohama City University
      Nov 15, 2021

      Nonalcoholic Fatty Liver Trial in United States (PXL770, Placebo Oral Capsule)

      Completed
      Has Results
      • Nonalcoholic Fatty Liver
      • Los Angeles, California
      • +14 more
      Oct 1, 2021

      Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis, Obesity Trial in Columbia (Phase II: Lifestyle treatment, Phase II:

      Recruiting
      • Nonalcoholic Fatty Liver
      • +2 more
      • Phase II: Lifestyle treatment
      • +2 more
      • Columbia, Missouri
        University of Missouri
      Oct 22, 2021

      Nonalcoholic Fatty Liver Trial in High Point (PXL770, Placebo)

      Completed
      • Nonalcoholic Fatty Liver
      • High Point, North Carolina
        High Point Clinical Trials Center
      Jun 8, 2021

      Type 2 Diabetes, Nonalcoholic Fatty Liver Trial in Tehran (curcumin, )

      Completed
      • Type 2 Diabetes
      • Nonalcoholic Fatty Liver
      • curcumin
      • placebo
      • Tehran, Iran, Islamic Republic of
        NNFTRI
      Sep 26, 2020

      Severity of Nonalcoholic Fatty Liver Disease

      Completed
      • Nonalcoholic Fatty Liver
      • Metabolic Syndrome
        • Thessaloniki, Greece
          Hippokration General Hospital
        Jun 13, 2019

        Nonalcoholic Steatohepatitis (NASH), Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis Trial in Durham (Vigorous-intensity

        Completed
        • Nonalcoholic Steatohepatitis (NASH)
        • +3 more
        • Vigorous-intensity interval training (VIIT)
        • Durham, North Carolina
          Duke Integrative Medicine
        Mar 1, 2019

        Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis Trial in Seoul (Imaging and serologic evaluation of fibrosis and

        Unknown status
        • Nonalcoholic Fatty Liver
        • Nonalcoholic Steatohepatitis
        • Imaging and serologic evaluation of fibrosis and steatosis
        • Seoul, Korea, Republic of
          Korea University Guro Hospital
        Oct 29, 2018

        Type II Diabetes, Nonalcoholic Fatty Liver Trial in Galveston (DPP4 inhibitor, Pioglitazone, Lantus insulin)

        Terminated
        Has Results
        • Type II Diabetes
        • Nonalcoholic Fatty Liver
        • DPP4 inhibitor
        • +2 more
        • Galveston, Texas
          University of Texas Medical Branch -Galveston
        Jul 5, 2018